Title: Immunochemistry - Humoral Immunity
1Immunochemistry Humoral Immunity
R. C. Gupta Professor and Head Dept. of
Biochemistry National Institute of Medical
Sciences Jaipur, India
2E M B - R C G
3E M B - R C G
4E M B - R C G
5E M B - R C G
6Innate immunity
E M B - R C G
7E M B - R C G
8E M B - R C G
9E M B - R C G
10E M B - R C G
11E M B - R C G
EMB-RCG
12Acquired immunity
E M B - R C G
13 Acquired immunity comprises
E M B - R C G
EMB-RCG
14Antigens
E M B - R C G
15E M B - R C G
16Haptens
E M B - R C G
17E M B - R C G
18Role of lymphocytes
E M B - R C G
19E M B - R C G
20E M B - R C G
21Humoral immunity
E M B - R C G
22(No Transcript)
23(No Transcript)
24Immunoglobulin light chains
Light chains are smaller than heavy chains
E M B - R C G
25E M B - R C G
26Immunoglobulin heavy chains
E M B - R C G
27E M B - R C G
28E M B - R C G
29(No Transcript)
30E M B - R C G
31(No Transcript)
32E M B - R C G
33E M B - R C G
34(No Transcript)
35E M B - R C G
36Action of papain
E M B - R C G
37E M B - R C G
38(No Transcript)
39Antigen-antibody interaction
E M B - R C G
40E M B - R C G
41Effector mechanisms
E M B - R C G
42Neutralization
E M B - R C G
43Neutralization
44Opsonisation
E M B - R C G
45Opsonisation
46Complement activation
E M B - R C G
47Complement activation
Phagocyte
Antibody
48Classification of immunoglobulins
E M B - R C G
49Immuno- globulin class Heavy chains Light chains
IgA a k or l
IgG g k or l
IgD d k or l
IgE e k or l
IgM m k or l
E M B - R C G
50Subclasses
E M B - R C G
51IgG
E M B - R C G
52EMB-RCG
53IgA
E M B - R C G
54(No Transcript)
55Secretory IgA
E M B - R C G
56(No Transcript)
57E M B - R C G
58IgM
E M B - R C G
59(No Transcript)
60 IgE
E M B - R C G
61EMB-RCG
62IgD
Function of IgD is not known
EMB-RCG
63Important features of Ig classes
Class of Ig
Plasma conc (mg/dl)
Half- life (days)
Active against
Bacteria and viruses
IgG
700-1,500
23
Strongly antiviral, weakly antibacterial
60-500
5-6
IgA
Strongly antibacterial, weakly antiviral
IgM
40-200
5-6
Anti-parasitic, mediates allergic reactions
IgE
0.01-0.1
2-3
Function not known
IgD
0.3-40
2-3
64E M B - R C G
EMB-RCG
65Idiotypes
E M B - R C G
66Idiotype
67Isotypes
E M B - R C G
68E M B - R C G
69Isotype
70Allotypes
E M B - R C G
71Allotype
72Antibody diversity
E M B - R C G
73E M B - R C G
74Human beings can synthesize millions of unique
antibodies
E M B - R C G
So, we need millions of genes to encode the
huge repertoire of antibodies
However, the number of antibody genes in human
genome is less than 200
75(No Transcript)
76Gene re-arrangement
E M B - R C G
77Light chain gene re-arrangement
E M B - R C G
78E M B - R C G
79E M B - R C G
80E M B - R C G
81E M B - R C G
82E M B - R C G
83E M B - R C G
84Light chain gene re-arrangement
85E M B - R C G
86E M B - R C G
87Heavy chain gene re-arrangement
E M B - R C G
88E M B - R C G
89E M B - R C G
90E M B - R C G
91E M B - R C G
92E M B - R C G
93Heavy chain gene-rearrangement
94E M B - R C G
95E M B - R C G
96Combinatorial diversity
E M B - R C G
97E M B - R C G
98Junctional diversity
E M B - R C G
99E M B - R C G
100Somatic hypermutation
E M B - R C G
101Re-arranged heavy chain gene
E M B - R C G
102(No Transcript)
103C Segments of heavy chain gene
104E M B - R C G
105Class switching
E M B - R C G
106E M B - R C G
107E M B - R C G
108Class switching from IgM to IgA2
109Primary response
E M B - R C G
110(No Transcript)
111E M B - R C G
112(No Transcript)
113E M B - R C G
114(No Transcript)
115E M B - R C G
116Secondary response
E M B - R C G
117(No Transcript)
118Differentiation of B cells into plasma
cells
E M B - R C G
119(No Transcript)
120E M B - R C G
121E M B - R C G
122E M B - R C G
123E M B - R C G
124E M B - R C G
125(No Transcript)
126E M B - R C G
127E M B - R C G
128Immunization
E M B - R C G
129E M B - R C G
130E M B - R C G
131E M B - R C G
132Features of an effective vaccine
The vaccine itself should not cause disease or
death
Safe
Must protect against illness from exposure to
live pathogen
Protective
Protection should be long-lasting
Sustained effect
EMB-RCG
133Passive immunity
E M B - R C G
134E M B - R C G
135Production of monoclonal antibodies
E M B - R C G
136E M B - R C G
137E M B - R C G
138E M B - R C G
139Procedure
E M B - R C G
140E M B - R C G
141E M B - R C G
142Production of monoclonal antibodies
143E M B - R C G
144In HAT medium
E M B - R C G
145(No Transcript)
146Complement system
E M B - R C G
147E M B - R C G
148E M B - R C G
149 E M B - R C G
150E M B - R C G
X ? Xa Xb
151E M B - R C G
152E M B - R C G
153Classic complement cascade
E M B - R C G
154E M B - R C G
155E M B - R C G
156E M B - R C G
157Recognition phase
E M B - R C G
158Complement system Recognition phase
159E M B - R C G
160(No Transcript)
161E M B - R C G
162(No Transcript)
163Membrane attack phase
C5a
C5
C8
C6 C7
164E M B - R C G
165(No Transcript)
166Lectin pathway
E M B - R C G
167E M B - R C G
168(No Transcript)
169(No Transcript)
170Alternate complement pathway
E M B - R C G
171E M B - R C G
172E M B - R C G
173E M B - R C G
174(No Transcript)
175E M B - R C G
176(No Transcript)
177Allergy
Allergy is described as a side effect of immunity
E M B - R C G
It is an altered immune response to an otherwise
innocuous antigen
Antigens evoking an allergic response are called
allergens
EMB-RCG
178(No Transcript)
179E M B - R C G
EMB-RCG
180E M B - R C G
EMB-RCG
181E M B - R C G
EMB-RCG
182EMB-RCG
183EMB-RCG
184E M B - R C G
EMB-RCG
185E M B - R C G
EMB-RCG